XML 33 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Reportable Segments
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Reportable Segments
Reportable Segments
The structure of our internal organization is divided into the following reportable segments, which are also our operating segments: E&C, D&S, and BioMedical. Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit, and risk management. Corporate support functions are not currently allocated to the segments.
The following table represents information for our reportable segments and our corporate function:
 
Three Months Ended March 31,
 
2018
 
2017
Sales
 
 
 
Energy & Chemicals (1)
$
89.9

 
$
39.9

Distribution & Storage
136.1

 
113.2

BioMedical
54.7

 
51.0

Intersegment eliminations
(1.0
)
 

Consolidated
$
279.7

 
$
204.1

Operating Income (Loss) (2)
 
 
 
Energy & Chemicals (1)
$
2.8

 
$
(0.2
)
Distribution & Storage
18.1

 
11.6

BioMedical
9.5

 
5.0

Corporate (3)
(13.5
)
 
(16.1
)
Consolidated
$
16.9

 
$
0.3

 _______________
(1) 
Includes Hudson net sales and operating income of $43.3 and $4.2 for the three months ended March 31, 2018, respectively.
(2) 
Includes restructuring costs of $0.9 and $4.6 for the three months ended March 31, 2018 and 2017 respectively.
(3) 
Includes transaction-related costs of $1.3 and $0.1 for the three months ended March 31, 2018 and 2017, respectively.